Blepharitis Clinical Trial
Official title:
Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis (Pilot Phase II Clinical Study, Multicentre, Randomised, Double Masked, Comparative, 2 X 40 Patients)
The primary objective of this study is to demonstrate the efficacy of T1225 eye drops versus placebo eye drops on the global ocular discomfort (VAS).
Currently, topical antibiotic ointments are used for blepharitis. They provide prolonged
contact time with the lid margin but with little penetration into eyelid tissue.
Azithromycin eye drops may offer on advantage over these preparations because azithromycin
achieves sustained high concentration in various ocular tissues including the lid margin.
Patients will be treated during 7 days (1 drop twice daily the first day following by one
drop once daily for 6 days) following by a period of 2 weeks without treatment. This
therapeutic scheme will be repeated two times.
Efficacy will be evaluated by change from baseline (Day 0) to Day 63 ± 3 Days of the global
ocular discomfort evaluation (VAS).
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04475432 -
Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis
|
Phase 2/Phase 3 | |
Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
Completed |
NCT05629390 -
Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study
|
Phase 3 | |
Terminated |
NCT02938078 -
Ocular Comfort and Inflammation in Lid Hygiene Therapy
|
N/A | |
Completed |
NCT01408082 -
Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis
|
Phase 3 | |
Completed |
NCT01028027 -
Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis
|
Phase 3 | |
Recruiting |
NCT04858113 -
Short-term Effects on Tear Film (Baby Shampoo vs Blephasol)
|
N/A | |
Completed |
NCT00560703 -
Treatment of Patients With Blepharitis and Facial Rosacea
|
Phase 2 | |
Recruiting |
NCT02455895 -
Efficacy of iLid Cleanser (Avenova) Versus Vehicle on Ocular Skin Flora
|
N/A | |
Completed |
NCT00894530 -
The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638)
|
Phase 2 | |
Completed |
NCT01115192 -
Blephacura Versus Baby Shampoo to Treat Blepharitis
|
N/A | |
Completed |
NCT02386774 -
Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa
|
N/A | |
Completed |
NCT01808560 -
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
|
N/A | |
Completed |
NCT00629590 -
Safety and Efficacy Pilot Study of AzaSite (Azithromycin) in Subjects With Blepharitis
|
Phase 4 | |
Completed |
NCT00629941 -
Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis
|
Phase 4 | |
Completed |
NCT03926026 -
Study Evaluating the Safety and Tolerability of NCX 4251 for the Treatment of Acute Exacerbations of Blepharitis
|
Phase 2 | |
Recruiting |
NCT04603222 -
Evaluation of SUMMIT BRUSH in Treatment of Blepharitis
|
N/A | |
Completed |
NCT02218489 -
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
|
Phase 2 | |
Completed |
NCT00796926 -
Trial to Compare the Efficacy of Systane Ultra and Refresh Drop in the Treatment of Dry Eye in Asian Eyes
|
Phase 3 | |
Completed |
NCT00803452 -
Lipids of the Human Tear Film and Their Effect on Tear Stability
|
Phase 4 |